Carnitine O -acetyltransferase Carnitine O -acetyltransferase (CrAT), located primarily in the mitochondrial matrix, catalyzes the addition or the removal of carnitine from medium- and short-chain acyl-CoA 60,61 , facilitating the efflux of mitochondrial acetyl-CoA to the cytosol and buffering the intracellular pools of acetyl-CoA and carnitine
Precision prevention and treatment approaches are specifically designed to address the issue of molecular and clinical heterogeneity by identifying a persons specific pattern of risk factors and/or underlying pathophysiologic processes and selecting a preventive or therapeutic intervention strategy that is likely to provide benefit
The economic burden is considerable: annual direct healthcare costs attributable to MASLD in the United States and Europe are estimated in the tens of billions of dollars, driven by hospitalizations, liver-related procedures, and management of comorbid conditions [6]
Simply stopping GLP-1 therapy without provider guidance and lifestyle support often results in metabolic disruption and return of appetite-regulation difficulties
Similarly, metformin is most effective when starting a new antipsychotic, before weight gain gets out of control
Li PQ, Ou S, Shi C, Shao